Ascentage Pharma Group International

AAPG

As of the close on Sep 25, 2026

Price

$14.86

Market cap

—

Figures are per ordinary share in the filer's currency; the US price is per depositary share

P/E (diluted TTM)

—

The last four quarters are not all on file

EPS (TTM)

—

The last four quarters are not all on file

Dividend yield

—

Figures are per ordinary share in the filer's currency; the US price is per depositary share

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Ascentage Pharma Group International Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Ascentage Pharma Group International — 20-F filed Apr 29, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 4 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 22, 2026.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Grants, exercises, tax & gifts

		Security	Code		Filing
2026-05-21	Yang Dajun · Chairman and CEO	Restricted stock units	M — Exercise or conversion of derivative security	−95,575	SEC filing
2026-05-21	Zhai Yifan · Chief Medical Officer	Ordinary Shares	M — Exercise or conversion of derivative security	+92,746	SEC filing
2026-05-21	Zhai Yifan · Chief Medical Officer	Restricted stock units	M — Exercise or conversion of derivative security	−95,575	SEC filing
2026-05-21	Yang Dajun · Chairman and CEO	Restricted stock units	M — Exercise or conversion of derivative security	−92,746	SEC filing
2026-05-21	Zhai Yifan · Chief Medical Officer	Restricted stock units	M — Exercise or conversion of derivative security	−92,746	SEC filing
2026-05-21	Yang Dajun · Chairman and CEO	Ordinary Shares	M — Exercise or conversion of derivative security	+95,575	SEC filing
2026-05-21	Yang Dajun · Chairman and CEO	Ordinary Shares	M — Exercise or conversion of derivative security	+92,746	SEC filing
2026-05-21	Zhai Yifan · Chief Medical Officer	Ordinary Shares	M — Exercise or conversion of derivative security	+95,575	SEC filing

Showing 8 of 18 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.